nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
CME Accreditation Page
|
|
|
2014 |
9 |
1 |
p. ix- 1 p. |
artikel |
2 |
Contents
|
|
|
2014 |
9 |
1 |
p. v-vii nvt p. |
artikel |
3 |
Contributors
|
|
|
2014 |
9 |
1 |
p. iii-iv nvt p. |
artikel |
4 |
18F-Fluorodihydroxyphenylalanine in the Diagnosis of Neuroendocrine Tumors
|
Minn, Heikki |
|
2014 |
9 |
1 |
p. 27-36 10 p. |
artikel |
5 |
Forthcoming Issues
|
|
|
2014 |
9 |
1 |
p. viii- 1 p. |
artikel |
6 |
68Ga-DOTA-peptides in the Diagnosis of NET
|
Ambrosini, Valentina |
|
2014 |
9 |
1 |
p. 37-42 6 p. |
artikel |
7 |
Index
|
|
|
2014 |
9 |
1 |
p. 113-115 3 p. |
artikel |
8 |
Nuclear Medicine Procedures in the Diagnosis of NET
|
Maffione, Anna Margherita |
|
2014 |
9 |
1 |
p. 1-9 9 p. |
artikel |
9 |
Other PET Tracers for Neuroendocrine Tumors
|
Koopmans, Klaas Pieter |
|
2014 |
9 |
1 |
p. 57-62 6 p. |
artikel |
10 |
Patient Selection for Personalized Peptide Receptor Radionuclide Therapy Using Ga-68 Somatostatin Receptor PET/CT
|
Kulkarni, Harshad R. |
|
2014 |
9 |
1 |
p. 83-90 8 p. |
artikel |
11 |
Preclinical Studies of SPECT and PET Tracers for NET
|
Brom, Maarten |
|
2014 |
9 |
1 |
p. 63-69 7 p. |
artikel |
12 |
Relevance of PET for Pretherapeutic Prediction of Doses in Peptide Receptor Radionuclide Therapy
|
Blaickner, Matthias |
|
2014 |
9 |
1 |
p. 99-112 14 p. |
artikel |
13 |
Role of 18F-Fluorodeoxyglucose PET in the Study of Neuroendocrine Tumors
|
Panagiotidis, Emmanouil |
|
2014 |
9 |
1 |
p. 43-55 13 p. |
artikel |
14 |
Single-Photon Emission Computed Tomography Tracers in the Diagnostics of Neuroendocrine Tumors
|
Pepe, Giovanna |
|
2014 |
9 |
1 |
p. 11-26 16 p. |
artikel |
15 |
Theranostics with Ga-68 Somatostatin Receptor PET/CT
|
Kulkarni, Harshad R. |
|
2014 |
9 |
1 |
p. 91-97 7 p. |
artikel |
16 |
Yttrium-Based Therapy for Neuroendocrine Tumors
|
Bodei, Lisa |
|
2014 |
9 |
1 |
p. 71-82 12 p. |
artikel |